In rats with pulmonary hypertension, we recently demonstrated that PETN interferes with ET-1 signaling (downregulation of ET-1, ECE-1, and ETA and ETB receptor mRNA expression), thereby improving cardiac and vascular function and reducing cardiovascular and pulmonary oxidative stress and inflammation [39]. Here, EDN1 is linked to pulmonary arterial hypertension.